Skip to main content

Advertisement

Log in

Increased resistance amongStaphylococcus epidermidis isolates in a large teaching hospital over a 12-year period

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The prevalence of drug resistance among clinically significant blood isolates ofStaphylococcus epidermidis (n=464) and consumption of antibiotics at a tertiary care teaching hospital (Meilahti Hospital, Helsinki) were analysed for the period 1983–1994. Resistance to methicillin increased from 28 to 77%. Simultaneously, usage of thirdgeneration cephalosporins increased nearly sevenfold (from 8.6 kg/ to 56.4 kg/year). A significant correlation was found between percentages of methicillin resistance and usage of penicillinase-stable β-lactam agents, including cloxacillin, imipenem, and first-, second-, and third-generation cephalosporins (r=0.737, p<0.0062). The increase in ciprofloxacin resistance occurred soon after the introduction of ciprofloxacin. Moreover, there was a remarkable increase in resistance to fusidic acid (from 10 to 40%) and rifampin (from 0 to 23%) despite the low usage of these agents. Overall, the rate of multiply resistant isolates roughly tripled (from 20 to 71 %) and, by 1994, the frequency of isolates susceptible to vancomycin only was as high as 11%, which remarkably limits options for therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Toison J, Henderson T, Martone WJ, the National Nosocomial infections Surveillance System: Secular trends in nosocomial infections in the United States 1980–1989. American Journal of Medicine 1991, 91, Supplement 3B: 86–89.

    Google Scholar 

  2. Rupp ME, Archer GL: Coagulase-negative staphylococci: pathogens associated with medial progress. Clinical Infectious Diseases 1994, 19: 231–245.

    Google Scholar 

  3. Archer GL:Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Mandell GL, Bennett JE, Dolin R (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1995, p. 1777–1784.

    Google Scholar 

  4. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 1991, 91, Supplement 3B: 72–75.

    Google Scholar 

  5. Kloos WE, Bannermann TL: Update on clinical significance of coagulase-negative staphylococci. Clinical Microbiology Reviews 1994, 7: 117–140.

    Google Scholar 

  6. Pallares R, Dick R, Wenzel RP, Adams RJ, Nettleman MD: Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978–1992). Infection Control and Hospital Epidemiology 1993, 14: 376–382.

    Google Scholar 

  7. Tullus K, Berglund B, Fryklund B, Kuhn I, Burman LG: Influence of antibiotic therapy on faecal carriage of P-fimbriatedEscherichia coli and other gram-negative bacteria in neonates. Journal of Antimicrobial Chemotherapy 1988, 22: 563–568.

    Google Scholar 

  8. Tullus K, Burman LG: Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet 1989, i: 1405–1407.

    Google Scholar 

  9. Neu HC: The crisis in antibiotic resistance. Science 1992, 257: 1064–1073.

    Google Scholar 

  10. Cohen ML: Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992, 257: 1050–1055.

    Google Scholar 

  11. Phaller MA, Herwaldt LA: Laboratory, clinical and epidemiological aspects of coagulase-negative staphylococci. Clinical Microbiology Reviews 1988, 1: 281–299.

    Google Scholar 

  12. Moller JK: Observations on multiple drug resistance in coagulase-negative staphylococci isolated in hospitals from 1975 to 1985. Journal of Hospital Infection 1988, 11:26–35.

    Google Scholar 

  13. Møller JK: Antimicrobial usage and microbial resistance in a university hospital during a seven-year period. Journal of Antimicrobial Chemotherapy 1989, 24: 983–992.

    Google Scholar 

  14. Tripodi MF, Attanasio V, Adinolfi LE, Florio A, Cione P, Cuccurullo S, Utili R, Ruggiero G: Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 148–152.

    Google Scholar 

  15. Archer GL, Tenenbaum MJ: Antibiotic-resistantStaphylococcus epidermidis in patients undergoing cardiac surgery. Antimicrobial Agents and Chemotherapy 1980, 17:269–272.

    Google Scholar 

  16. Kernodle DS, Barg NL, Kaiser AB: Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrobial Agents and Chemotherapy 1988, 32: 202–208.

    Google Scholar 

  17. Mouton RP, Hermans J, Simoons-Smit AM, Hoogkamp-Korstanje JAA, Degener JE, van Klingeren B: Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. Journal of Antimicrobial Chemotherapy 1990, 26: 573–583.

    Google Scholar 

  18. Nyström B, Ransjö U, Ringertz S, Faxelius G, Tunell R, Öhman G, Wilton J, Pfaller MA: Colonization with coagulase-negative staphylococci in two neonatal units. Journal of Hospital Infection 1992, 22: 287–298.

    Google Scholar 

  19. Oppenheim BA, Hartley JW, Lee W, Burnie JP: Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. British Medical Journal 1989, 299: 294–297.

    Google Scholar 

  20. Etienne J, Brun Y, Billard M, Fleurette J: Hospital dispersion ofStaphylococcus epidermidis isolates resistant to a fluoroquinolone, pefloxacin. Epidemiology and Infection 1989, 103:459–464.

    Google Scholar 

  21. Kotilainen P, Nikoskelainen J, Huovinen P: Emergence of ciprofloxacin resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. Journal of Infectious Diseases 1990, 161:41–44.

    Google Scholar 

  22. Dryden MS, Talsania H, McCann M, Cookson BD, Phillips I: The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiology and Infection 1992, 109: 97–112.

    Google Scholar 

  23. Schwalbe RS, Stapleton JT, Gilligan PH: Emergence of vancomycin resistance in coagulase-negative staphylococci. New England Journal of Medicine 1987, 316: 927–931.

    Google Scholar 

  24. Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH: Selection for vancomycin resistance in clinical isolates ofStaphylococcus haemolyticus. Journal of Infectious Diseases 1990, 161: 45–51.

    Google Scholar 

  25. Ena J, Dick RW, Jones RN, Wenzel RP: The epidemiology of intravenous vancomycin usage in a university hospital: a 10 year study. Journal of the American Medical Association 1993, 269: 598–602.

    Google Scholar 

  26. Swartz MN: Hospital-acquired infections: diseases with increasingly limited therapies. Proceedings of the National Academy of Sciences of the USA 1994, 91: 2420–2427.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyytikäinen, O., Vaara, M., Järviluoma, E. et al. Increased resistance amongStaphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur. J. Clin. Microbiol. Infect. Dis. 15, 133–138 (1996). https://doi.org/10.1007/BF01591486

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01591486

Keywords

Navigation